Citadel Advisors - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q1 2021$4,887,000
-51.7%
208,948
-40.6%
0.00%
-50.0%
Q4 2020$10,126,000
+11.1%
351,589
-21.9%
0.00%
-33.3%
Q3 2020$9,116,000
+11.2%
449,905
+64.9%
0.00%0.0%
Q2 2020$8,198,000
+137.0%
272,814
+147.9%
0.00%
+200.0%
Q1 2020$3,459,000
-42.5%
110,047
-13.8%
0.00%
-66.7%
Q4 2019$6,012,000127,6300.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders